A Tata memorial centre led study concludes that 50% oral cancer patients die within a year of diagnosis

INDIA – The first-of-its-kind study on the ‘cost of illness analysis of oral cancer’, conducted by Tata Memorial Centre in Mumbai, reveals that half of oral cancer patients in India die within a year of diagnosis and are aged between 30-50 years. The study was conducted on 100 consecutive oral cancer patients who sought treatment at the facility between October 2019 and March 2020 and pointed out that most of the patients who receive some form of treatment are left unemployed hence they become an economic burden to their families.…

Read More

Merck Foundation calls for action together with African First Ladies and Ministers to Build Healthcare Capacity

ZAMBIA – Merck foundation “More than a Mother” Ambassadors, African First Ladies of Angola, Botswana, Burkina Faso, Burundi, Central African Republic, Democratic Republic of Congo, Ghana, Guinea Conakry, Liberia, Malawi, Mozambique, and Namibia actively participated in the 8th edition of Merck Foundation Africa Asia Luminary which was co-chaired by Zambia First Lady, H.E. Esther Lungu and Merck Foundation CEO, Senator, Dr. Rasha Kelej. Merck Foundation, the philanthropic arm of Merck KgaA, conducted the 8th Edition of “Merck Foundation Africa Asia Luminary” 2021, through an online video conference. During the Luminary,…

Read More

Max Healthcare collaborates with digital health solutions to launch a remote healthcare monitoring system

INDIA – Max Healthcare, a giant Indian based corporation in the healthcare sector, has launched an artificial intelligence (AI) powered device integrated patient monitoring framework, claimed to be the first in the country. The project was a success owing to the fact that Max Healthcare collaborated with digital health solutions, an Indian social business that uses technology and creativity to make high-quality health services. This was a move Max Healthcare undertook in a bid to expand its geography of care, allowing patients from across India and globally to stay connected…

Read More

Bayer’s Astepro approved for over the counter use in the US

US – The US Food and Drug Administration (FDA) has approved Bayer’s steroid-free antihistamine nasal spray Astepro for over-the-counter use. Astepro becomes the first and only OTC steroid-free antihistamine nasal spray available in the US for adults and children aged six years and older. Currently, OTC allergy medications is classified into three major classes which include antihistamines, intranasal steroids and mast cell stabilizers. Bayer, a German multinational pharmaceutical and life sciences company had astepro previously approved for prescription use in 2008. Following the approval by the FDA, Astepro will be…

Read More

Islamic Development Bank fruitfully cements alliance to fight avoidable blindness in Djibouti

DJIBOUTI – The Islamic Development Bank (IsDB), the Alliance to Fight Avoidable Blindness (AFAB), and the Islamic Solidarity Fund for Development (ISFD) have successfully executed cataract surgery campaigns in the city of Djibouti and its surrounding rural localities. This has been accomplished in their second phase of efforts to fight avoidable blindness which has seen 11,709 patients receive vision screening with 1,032 cataract treatment surgeries conducted, in addition to providing post-surgical monitoring and visits to patients in Djibouti. “My sincere thanks to the Islamic Development Bank and the Azerbaijan International…

Read More

Roche launches first cancer treatment center in Ghana for effective cancer care

GHANA – Roche, a global pioneer in pharmaceuticals and diagnostics and the leading provider of cancer treatments globally, has launched a cancer treatment center at the Cape Coast Teaching Hospital (CCTH) for accessible and effective cancer care in the Region and beyond. It is the first of three cancer centers to be established by Roche, in collaboration with the Ministry of Health to provide and promote effective and efficient cancer care and bring treatment closer to the door steps of people affected with the disease. The launch coincided with the…

Read More

India’s pharmaceutical pricing authority issues new guidelines on pricing of drugs

INDIA -The Nationwide Pharmaceutical Pricing Authority (NPPA) has directed all producers and advertising firms of medication, formulations and medical gadgets to cut back costs of merchandise already available in the market NPPA has asked all producers and advertisers to revise their utmost retail cost of medications on which Goods and Service Tax (GST) have been diminished. The regulatory body has requested the involved parties to recall, relabel products of launched shares available in the market in order to have them meet the regulatory compliance. Producers will be made accountable for…

Read More

Bharat Biotech’s covaxin inches closer to the WHO’s emergency use listing

INDIA – Following an acceptance of its expression of interest by World Health Organization (WHO), Bharat’s covaxin could make it to the emergency use listing (EUL) after providing WHO with additional data. Bharat Biotech is a pioneering biotechnology company known for its world-class R&D and manufacturing capabilities and is the brainchild behind covaxin among numerous drugs. The pre-submission meeting of the vaccine maker with WHO has been planned in reference to the WHO EUL guidance document that was uploaded on the WHO website. A WHO EUL would open doors of…

Read More

Joseph Biden’s administration pumps in US$3.2bn for the development of a COVID-19 drug

US – The US government is taking another leap into the fight against COVID-19 through an investment worth US$3.2 billion to help develop antiviral therapy pills. This is part of the American Rescue Plan (ARP) government strategy to develop the next generation of COVID-19 treatments. ARP was developed to provide emergency grants, lending, and investment to hard-hit small businesses during the pandemic. This plan will provide more than $300 million for research and lab support, nearly $1 billion for preclinical and clinical evaluation, and nearly $700 million for development and…

Read More

Somaliland Signs Medical Cooperation Deal with Taiwan to improve healthcare services

SOMALILAND – Somaliland and Taiwan on Thursday signed a medical cooperation agreement that will see improvement of healthcare services in the Horn of Africa nation. The agreement signed between Taiwan minister of Foreign Affairs of the Republic of China (Taiwan) H.E. Jaushieh Joseph Wu and H.E. Liban Yusuf Osman, Acting Minister of Ministry of Foreign Affairs and International Development of the Republic of Somaliland is aimed at improving the problem of high maternal and neonatal mortality Minister Wu stated the medical care is the key area of bilateral cooperation between…

Read More